Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis

  1. Rémi Goupil
  2. Mehdi Benlarbi
  3. William Beaubien-Souligny
  4. Annie-Claire Nadeau-Fredette
  5. Debashree Chatterjee
  6. Guillaume Goyette
  7. Lakshman Gunaratnam
  8. Caroline Lamarche
  9. Alexander Tom
  10. Andrés Finzi
  11. Rita S. Suri

Reviewed by

Read the full article

Listed in

Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1503/cmaj.210673
  2. Version published to 10.1101/2021.03.30.21254652v2 on medRxiv
  3. ScreenIT

    SciScore for 10.1101/2021.03.30.21254652: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board StatementIRB: This study was approved by the local research ethics board and patients provided written informed consent.
    Consent: This study was approved by the local research ethics board and patients provided written informed consent.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.

    Table 2: Resources

    Antibodies
    SentencesResources
    Bovine serum albumin and CR3022 monoclonal antibody (mAb) against SARS-CoV-2 S glycoprotein were used as negative and positive controls, respectively.
    CR3022
    suggested: None
    SARS-CoV-2 S glycoprotein
    suggested: None

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).

    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.

    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.

    Results from JetFighter: We did not find any issues relating to colormaps.

    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.

  4. Version published to 10.1101/2021.03.30.21254652v1 on medRxiv